Editorial: ACA drives reform, innovation

The Affordable Care Act’s goal to promote reforms to the "overpriced, underperforming" U.S. healthcare system is often overlooked in the healthcare debate sweeping the country right now, argues New York Times op-ed columnist Bill Keller.

The law is spurring innovation and efficiency, he writes, citing the proliferation of accountable care organizations, which he describes as the “Silicon Valley of preventative care, laboratories of invention driven by the entrepreneurial energy of start-ups.”

To read more of Keller’s examples of ACA-inspired innovation—including efforts at major businesses like Walgreens, CVS and Walmart—check out the editorial below:

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.